肿瘤源性腺苷通过GM-CSF协同促进肝细胞癌巨噬细胞增殖
该研究探讨人肝细胞癌(HCC)中增殖巨噬细胞的贡献、表型及调控机制。流式细胞术和双重免疫荧光显示肿瘤浸润巨噬细胞增殖能力显著高于非肿瘤组织,且与巨噬细胞密度和不良预后正相关。肿瘤细胞来源的可溶性小分子腺苷与巨噬细胞自分泌的GM-CSF协同,通过上调A2A受体促进巨噬细胞增殖。
要点
- 肿瘤浸润巨噬细胞增殖能力显著高于非肿瘤组织,且与密度和不良预后正相关。
- 增殖巨噬细胞分化程度较低,CD206表达增加。
- 肿瘤源性腺苷与自分泌GM-CSF协同上调A2A受体,促进巨噬细胞增殖。
核心结论
- 局部巨噬细胞增殖是HCC组织巨噬细胞积聚的重要机制。
- 肿瘤源性腺苷与活化的巨噬细胞自分泌的GM-CSF协同促进巨噬细胞增殖。
- 选择性调控巨噬细胞积聚来源可能为癌症治疗提供新策略。
研究设计与样本
- 研究采用流式细胞术分析新鲜HCC组织中增殖巨噬细胞的存在和表型。
- 采用双重免疫荧光染色分析增殖巨噬细胞的预后价值。
- 使用人单核细胞衍生的巨噬细胞研究潜在调控机制。
主要发现
- 肿瘤浸润巨噬细胞增殖能力显著高于非肿瘤组织巨噬细胞。
- 巨噬细胞增殖水平较高与肿瘤中巨噬细胞密度和HCC患者不良预后正相关。
- 增殖巨噬细胞分化程度较低,CD206表达增加。
- 肿瘤细胞来源的可溶性小分子腺苷(而非蛋白质、脂质或大肽)诱导巨噬细胞增殖。
- 肿瘤刺激的巨噬细胞释放的自分泌GM-CSF增强巨噬细胞A2A受体表达,并与腺苷协同诱导HCC中巨噬细胞增殖。
临床怎么用
- 选择性调控巨噬细胞积聚来源可能为癌症治疗提供新策略。
- 靶向腺苷-GM-CSF-A2A受体轴可能抑制HCC中巨噬细胞积聚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Macrophages (Mϕ) represent a major component of tumor tissues and play an important role in both tumor progression and therapeutic response. Although tumor Mϕ are generally considered to be derived from circulating monocytes, emerging evidence indicates that tissue Mϕ pools can be maintained by self-renewal. We aimed to elucidate the contribution, phenotype, and regulatory mechanisms of proliferating Mϕ in human hepatocellular carcinoma (HCC). METHODS: Flow cytometry analyses were performed to examine the presence and phenotype of proliferating Mϕ in fresh HCC tissues. Dual immunofluorescence staining was applied to analyze the prognostic value of proliferating Mϕ. The underlying regulatory mechanisms were examined using human monocyte-derived Mϕ. RESULTS: Tumor-infiltrating Mϕ exhibited a significantly higher proliferative capacity than Mϕ in non-tumor tissues. A higher level of Mϕ proliferation was positively correlated with Mϕ density in the tumor and a poor prognosis in patients with HCC. Proliferating Mϕ were less differentiated (with increased CD206 expression) and were induced by the tumor cell-derived soluble small molecule, adenosine, but not proteins, lipids, or large peptides. Mechanistic studies demonstrated that autocrine granulocyte-macrophage colony-stimulating factor (GM-CSF) released by tumor-stimulated Mϕ could enhance A2A receptor expression on Mϕ and function synergistically with adenosine to elicit Mϕ proliferation in HCC. CONCLUSIONS: Local Mϕ proliferation is an important mechanism for Mϕ accumulation in HCC tissues. Tumor-derived adenosine functions synergistically with autocrine GM-CSF released from activated Mϕ, which promotes Mϕ proliferation. Thus, selective modulation of Mϕ accumulation at the source may provide a novel strategy for cancer therapy. LAY SUMMARY: Tumor-associated macrophages (TAMs) have been reported to play an essential role in both tumor progression and therapeutic response. A fundamental understanding of the mechanisms that regulate macrophage accumulation in tumors will undoubtedly lead to the development of strategies to target macrophages with high specificity and efficiency. The current study unveils a novel mechanism by which local proliferation is linked to macrophage accumulation in the tumor milieu, identifying potential targets for future immune-based anticancer therapies.
引用
- Wang J, Wang Y, Chu Y, et al. Tumor-derived adenosine promotes macrophage proliferation in human hepatocellular carcinoma. J Hepatol. 2020. PMID: 33137360. doi:10.1016/j.jhep.2020.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。